Atlas Trials

Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response

Clinical trial NCT00518154 · COMPLETED

Trial details

NCT number
NCT00518154
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2007-09-01
Primary completion
2008-11-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.